Growth Metrics

Teladoc Health (TDOC) Shares Outstanding (Weighted Average) (2016 - 2025)

Teladoc Health's Shares Outstanding (Weighted Average) history spans 13 years, with the latest figure at $176.2 million for Q4 2025.

  • For Q4 2025, Shares Outstanding (Weighted Average) rose 3.32% year-over-year to $176.2 million; the TTM value through Dec 2025 reached $176.2 million, up 3.32%, while the annual FY2025 figure was $176.2 million, 3.32% up from the prior year.
  • Shares Outstanding (Weighted Average) for Q4 2025 was $176.2 million at Teladoc Health, roughly flat from $175.7 million in the prior quarter.
  • Across five years, Shares Outstanding (Weighted Average) topped out at $176.2 million in Q4 2025 and bottomed at $152.2 million in Q1 2021.
  • The 5-year median for Shares Outstanding (Weighted Average) is $164.1 million (2023), against an average of $165.3 million.
  • The largest annual shift saw Shares Outstanding (Weighted Average) surged 108.3% in 2021 before it rose 1.35% in 2023.
  • A 5-year view of Shares Outstanding (Weighted Average) shows it stood at $156.9 million in 2021, then increased by 2.88% to $161.5 million in 2022, then grew by 1.93% to $164.6 million in 2023, then grew by 3.64% to $170.6 million in 2024, then grew by 3.32% to $176.2 million in 2025.
  • Per Business Quant, the three most recent readings for TDOC's Shares Outstanding (Weighted Average) are $176.2 million (Q4 2025), $175.7 million (Q3 2025), and $175.9 million (Q2 2025).